Yahoo Web Search

Search results

    • Small Business - Austin Daily Herald | Austin Daily Herald

      Austin Daily Herald· 3 days ago

      Iovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. The Iovance TIL platform ...

    • Tuesday Morning News Roundup

      San Francisco Chronicle· 6 days ago

      Below ground at the Salesforce Transit Center in downtown San Francisco is a train portal without tunnel connections. On Monday, city, state and national leaders announced $3.4 billion in federal ...